Navigation Links
Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas
Date:9/2/2014

AVENTURA, Fla., Sept. 2, 2014 /PRNewswire/ -- Technology Applications International Corporation (the "Company" or "NUUU")(OTC BB: NUUU) has announced that its wholly-owned subsidiary Renuell Int'l, Inc. has signed an additional exclusive licensing agreement with the National Aeronautics and Space Administration ("NASA") at the Johnson Space Center in Houston, Texas. 

See photos: tapplic.com/houstonphotos/

Charles J. Scimeca, NUUU's CEO stated, "We are very pleased to announce our latest, exclusive agreement with NASA. In addition to our original agreement, we now have exclusive usage rights, for cosmetics and hair care products, of an electromagnetic field (EMF) rotating-walled (RW) bioreactor, for commercial production of three-dimensional (3-D) expanded plant and mammalian cell cultures, including but not limited to cultures and co-cultures of human dermal cells, induced pluripotent cells, mammalian stem cell extracts and plant stem cell extracts."

About Technology Applications Corporation

NUUU has two wholly owned subsidiaries, Renuell Int'l, Inc. and NueEarth, Inc.

NUUU's Renuell Int'l, Inc. is launching its REJUVEL brand of technologically advanced breakthrough anti-aging skin care products that are made possible because of its agreements with NASA. NUUU's newest exclusive agreement covers two additional U.S. patents, No. 6,485,963 B1 and No. 6,673,597 B2. The patented invention is entitled "Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof."

REJUVEL anti-aging products are created in simulated microgravity, in NASA developed bioreactors, to create high quality skin care products that promote the body's own healing mechanisms. All products are "Space Certified" and are recognized by the Space Foundation as technology that has been developed in outer space. The Space Foundation Seal will appear on all of their products.

Renuell Int'l, Inc. is a "cruelty free" Company and as such does no new animal testing in any phase of product development either directly or indirectly through their laboratories or suppliers, and are members of the "Leaping Bunny" program (leapingbunny.org).

NUUU's NueEarth, Inc., subsidiary is engaged in the development of environment solutions using electron particle beam technology (E-Beam). The E-Beam works by using an electron beam particle accelerator unit that creates high energy electrons which produce free radicals in the waste water leading to decomposition of organic compounds (pollutants). The Company plans to develop various applications to use the E-Beam technology for removal of pollutants from wastewater, drinking water, municipal sludge and fracking liquids.

The Company will update their shareholders and the public on company developments through additional press releases as events warrant.

For more information about NUUU please visit the corporate websites at: www.tapplic.com and www.rejuvel.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contact:

Technology Applications International Corporation (NUUU)
Charles J. Scimeca, (800) 670-0448
President and CEO
info@tapplic.com
www.rejuvel.com

Logo - http://photos.prnewswire.com/prnh/20140825/139382


'/>"/>
SOURCE Technology Applications International Corporation
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
2. Positive Clinical Study Results for BSPs HyperQ Technology
3. Arizona State University engineers aim to improve performance of technology in extreme environments
4. iBioLaunch™ Technology Successfully Applied to Modified C1 Inhibitor
5. Pitt discoveries in quantum physics could change face of technology
6. Verenium to Present at Baird Clean Technology Conference
7. Puma Biotechnology Announces Completion of Private Placement
8. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
9. Animal Biotechnology - Technologies, Markets and Companies
10. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
11. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 - New FDA action date of ... FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast has ... indicated for the treatment of signs and symptoms of dry eye ... potential to be the only product approved in the U.S. in the past decade indicated ...
(Date:2/4/2016)... , Feb. 4, 2016 Beike Biotechnology, the ... medical institutions attended a ceremony in late 2015 to ... cell therapy in 2016. --> ... Translation Platform for Personalized Cell Therapy" was hosted by ... Production Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... 4, 2016 Strasbourg, France ... --> Strasbourg, France , to the ... PharmaVentures is pleased to announce that it acted as an ... unit in Strasbourg, France , to the ... --> --> Transgene (Euronext: TNG), a member ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
(Date:2/1/2016)... YORK , Feb. 1, 2016  Today, the ... Association (AHA) announced plans to develop a first of ... computing power of IBM Watson. In the first application ... AHA, IBM (NYSE: IBM ), and Welltok will ... and health assessments with cognitive analytics, delivered on Welltok,s ...
Breaking Biology News(10 mins):